Thromboxane A2 receptor antagonism selectively reverses platelet aggregation.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D001095:Arachidonic Acids / Q000494:pharmacology*; D004837:Epinephrine / Q000494:pharmacology; D005227:Fatty Acids / Q000494:pharmacology*; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology; D007700:Kinetics; D010974:Platelet Aggregation / Q000187:drug effects*; D011450:Prostaglandin Endoperoxides, Synthetic / Q000494:pharmacology; D011466:Prostanoic Acids / Q000494:pharmacology*
D001095:Arachidonic Acids; D005227:Fatty Acids; D011450:Prostaglandin Endoperoxides, Synthetic; D011466:Prostanoic Acids; D000244:Adenosine Diphosphate; C022574:13-azaprostanoic acid; D007213:Indomethacin; D004837:Epinephrine